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Abstract
Recent studies have shown that Plasmodium falciparum malaria parasites in Pailin province, along the border between
Thailand and Cambodia, have become resistant to artemisinin derivatives. To better define the epidemiology of P.
falciparum populations and to assess the risk of the possible spread of these parasites outside Pailin, a new epidemiological
tool named ‘‘Focused Screening and Treatment’’ (FSAT), based on active molecular detection of asymptomatic parasite
carriers was introduced in 2010. Cross-sectional malariometric surveys using PCR were carried out in 20 out of 109 villages in
Pailin province. Individuals detected as P. falciparum carriers were treated with atovaquone-proguanil combination plus a
single dose of primaquine if the patient was non-G6PD deficient. Interviews were conducted to elicit history of cross-border
travel that might contribute to the spread of artemisinin-resistant parasites. After directly observed treatment, patients were
followed up and re-examined on day 7 and day 28. Among 6931 individuals screened, prevalence of P. falciparum carriers
was less than 1%, of whom 96% were asymptomatic. Only 1.6% of the individuals had a travel history or plans to go outside
Cambodia, with none of those tested being positive for P. falciparum. Retrospective analysis, using 2010 routine surveillance
data, showed significant differences in the prevalence of asymptomatic carriers discovered by FSAT between villages
classified as ‘‘high risk’’ and ‘‘low risk’’ based on malaria incidence data. All positive individuals treated and followed-up until
day 28 were cured. No mutant-type allele related to atovaquone resistance was found. FSAT is a potentially useful tool to
detect, treat and track clusters of asymptomatic carriers of P. falciparum along with providing valuable epidemiological
information regarding cross-border movements of potential malaria parasite carriers and parasite gene flow.
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Introduction
The border region between Cambodia and Thailand, specifi-
cally in Pailin province, has repeatedly been the epicenter of
emerging resistance of Plasmodium falciparum to antimalarial drugs
since the 1960s [1]. This started with resistance to chloroquine
(CQ) first reported in 1959 [2], followed by resistance to
sulfadoxine-pyrimethamine in 1980’s [3] and, more recently,
mefloquine [4,5]. In response to increasing levels of drug
resistance, Cambodian and Thai national malaria control
programmes adapted their national treatment policies. Artemisi-
nin-based combination therapies (ACTs) were implemented as the
first-line treatment for uncomplicated falciparum malaria in
Thailand in 1995 and in Cambodia in 2000. During the last
decade, results from annual routine therapeutic efficacy studies
conducted in Cambodia have demonstrated that the efficacy of
artesunate-mefloquine and artemether-lumefantrine for the treat-
ment of falciparum malaria was declining in several areas of the
country [6–8]. In 2007, the World Health Organization (WHO)
initiated an informal consultative workshop in Phnom Penh,
Cambodia, during which available evidence regarding the
emergence of P. falciparum AR parasites was reviewed [9].
Following this meeting, a comprehensive clinical study clearly
demonstrated that parasite clearance times were uniformly
delayed in patients in Pailin compared to patients at the
Myanmar-Thailand border, justifying further research and action
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[10]. In this context, in order to prevent the possible spread of P.
falciparum AR parasites, the ‘‘Artemisinin-Resistance Containment
Project’’ was implemented by the governments of Cambodia and
Thailand with coordination and technical support by WHO and
partners with funding from the Bill & Melinda Gates Foundation.
Its overall goal was to contain artemisinin-tolerant P. falciparum
parasites by removing selection pressure and reducing and
ultimately eliminating falciparum malaria. In order to achieve
this goal, an ambitious programme of activities was carried out,
including the provision of universal coverage with long-lasting
insecticide treated nets (LLINs) and of rapid access to free,
parasitologically confirmed diagnosis through rapid diagnostic test
(RDT) and ACTs delivered by community-based Village Malaria
Workers (VMWs).
Initially, a much wider operation referred to as ‘‘Mass Screening
and Treatment’’ (MSAT), which aims at screening and treating
the entire population of Pailin, estimated at over 70,000, within
two weeks was envisaged but abandoned following two pilot
studies conducted in November 2008 and May 2009. It was
therefore decided to carry out to evaluate Focused Screening and
Treatment (FSAT), a PCR-based strategy intended to detect P.
falciparum asymptomatic carriers. PCR-based cross sectional
screenings were focused on villages with the highest annual
incidence rates for acute P. falciparum malaria infections reported
by heath centers (HC) through malaria microscopy and by VMWs
using RDT. Based on high-throughput molecular diagnosis of
malaria, the present paper compiles information obtained through
the FSAT pilot with a view to gaining more micro-epidemiological
knowledge about the population of asymptomatic carriers which
would otherwise have remained largely undetected.
Materials and Methods
Study sites & Participants
Based on the observation that the incidence of parasitologically
confirmed malaria cases in general and that of P. falciparum in
particular was highly clustered in Pailin, the 109 villages of Pailin
were split into two groups: ‘‘high risk’’ villages and ‘‘low risk’’
villages based on available records of parasitologically confirmed
symptomatic cases of P. falciparum malaria (2009). The ‘‘high risk’’
village group consisted of the 10 villages reporting the highest P.
falciparum incidence rates at HC and of 8 villages reporting the
highest number of cases through VMWs in 2009. All others were
classified as ‘‘low risk’’ villages. As three villages of Pailin qualified
Figure 1. Spatial distribution of the selected villages, Pailin, Cambodia, 2010.
doi:10.1371/journal.pone.0045797.g001
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for ‘‘high risk’’ in both categories (HC and VMW records), only 15
out of Pailin’s 109 villages were identified as ‘‘high risk’’, the
remaining 94 were classified as ‘‘low risk’’. All 15 ‘‘high risk’’
villages were selected, comprising among them 71% of all
parasitologically confirmed cases of P. falciparum malaria recorded
in Pailin in 2009 (623/941). The 2009 village selection threshold
between ‘‘high risk’’ and ‘‘low risk’’ villages was .8 cases of P.
falciparum with high risk villages reporting 9 to 78 (average 41.5)
cases and low risk reporting 0 to 7 (average 3.4) cases throughout
2009 (CNM and Malaria Consortium, unpublished data). The
‘‘high risk’’ villages included seven villages (Krachab Krom,
Krachab Leu, Phnom Rang, Oh Roel, Bor Thmey, Bor Tang Sou
and Phnom Spung) classified as ‘‘high risk HC 2009’’, five villages
(Oh Preus, Oh Sour Sdey, Andong Thmor, Pekiri and Andong Py)
classified as ‘‘high risk VMW 2009’’ and three villages (Phnom
Dambang, Prey Mang Kul, Oh Treng) classified as ‘‘high risk
HC/VMW 2009’’. Five villages (Oh Tatus, Rothkros Chhes, Oh
Tontram Dey, Oh Char Kandal, Phitas Sbov) were randomly
selected among the remaining 94 of 109 villages, classified as ‘‘low
risk 2009’’ (Figure 1).
Field procedures: samples collection and workflow of the
screening phase
FSAT interventions were conducted at a rate of 3 villages per
month. The Screening Team (ST) of seven persons spent four days
in each village. The ST was followed at a one-week interval by the
Follow-up and Treatment Team of two persons (FTT). Both ST
and FTT received local support by the active participation of the
village chief in identifying the individuals participating as well as
the VMW assisting the direct observation of treatment of those
found positive by RDT or PCR. The ST proceeded to the next
village and so on until it had screened three villages, before taking
one week’s rest. During the 4th week, the FTT completed the third
village and rested during week 5. In the week prior to
commencement of screening, the ST members visited the village
and met the village chief and the VMW. They conducted a
detailed joint planning discussion based on the village’s logistic and
geographical organization (examining the village family register,
gaining an idea of how many individuals were likely to turn up at
screening, and following recommendations of the village chief on
the best locations to set up the screening). Procedures to screen
individuals were divided among 4 dedicated stations:
Registration and Informed Consent. Two ST members,
assisted by the village chief, located each villager in the existing
village register. The villager’s name was manually transcribed into
the FSAT screening register with a unique ID code (village
number+family number+letter designating position in the famil-
y+screening sequence number). Absent family members were also
recorded. In order to assess the risk of spread of drug resistance,
the individuals were questioned regarding travel over the past year
and classified as ‘‘risk class A’’ (travel to or from Myanmar), ‘‘risk
class B’’ (travel to or from Thailand), ‘‘risk class C’’ (travel within
Pailin Province only) and ‘‘risk class D’’ (travel elsewhere within
Cambodia). The screening process was explained to each villager,
prior to signing or thumb-printing of the consent form.
Temperature Check. Axillary temperature was recorded for
each participant and the result transmitted immediately back to
the registration and informed consent station. Individuals with
temperature $37.2uC received an additional mark on their arm,
indicating that they would require a malaria rapid diagnostic test
(RDT).
Laboratory Station. Any individuals detected as being sub-
febrile or febrile were tested for malaria by using a RDT
(CareStart, Access Bio IncH, Somerset, NJ, USA), detecting
falciparum malaria (HRP-2) and non-falciparum malaria (lactate
dehydrogenase). If the result was positive, a mark was made on the
villager’s forearm, identifying him/her for the malaria treatment
station. For all participants in the survey, finger prick blood
samples were collected and used to perform thick and thin films
and double blood spots (one blood spot in 96 well-format PCR
plate and one classical blood spot as backup). For quality control,
in each 96 well-format PCR plate, one field positive and one
negative blood spot controls was included by the ST and blinded
to laboratory staff at the Pasteur Institute in Cambodia (IPC) in
Phnom Penh, which carried out the PCR tests.
Treatment Station. At the treatment station, RDT positive
cases were treated for P. falciparum with atovaquone-proguanil (AP,
MalaroneH, GlaxoSmithKlineH) according to manufacturer’s
instruction or with CQ for non-P. falciparum infections (chloroquine
phosphate TabletsH, MedopharmH), according to the national
treatment guideline. Prior to treatment, pregnant women were
detected through questioning and a pregnancy rapid diagnostic
test, if necessary. Pregnant women received quinine (10 mg/kg,
eight-hourly67 days). As soon as the patient received the first dose
of treatment, a detailed follow-up interview was conducted. RDT
negative cases received multivitamins and anti-helminthic treat-
ment, and if symptomatic with fever and other clinical signs of
bacterial infection, co-trimoxazole. At the completion of screening
in each village, slides and dried blood spot samples were
transported within 24 hours to the IPC laboratory in Phnom
Penh.
Field procedures: follow-up of PCR-positive cases
Follow-up was triggered when the list of PCR positive cases
including species identification, identification of Y268N mutation
in cytochrome b gene and G6PD status was transmitted to the
FTT from IPC by SMS. PCR-confirmed cases of P. falciparum
infections were treated with AP in absence of mutation at codon
268 in cytochrome b gene. Direct observed treatment at dosages
following manufacturer recommendation was carried out over
three days. Malaria cases were followed up daily for the first three
days and on day 7 and day 28. Primaquine (PQ) was used
according to G6PD status. Individuals with normal G6PD levels
and infected with P. falciparum received a single dose of PQ
(0.75 mg/kg, Cipla LtdH, India) under supervision on day 2, while
normal G6PD infected by P. vivax received CQ over three days
according to WHO guidelines and PQ for 14 days (0. 50 mg/kg).
Any patients presenting with severe symptoms were given
emergency support and referred to the Pailin referral hospital
for further assessment and management. Blood was obtained by
finger prick on all follow-up days and on any unscheduled day to
use for analysis of thick and thin blood smears and for storage on
filter paper.
Treatment outcomes
Treatment outcomes were classified as treatment failure if the
patient presented with recurrent asexual parasitemia at day 7 or
day 28 and treatment success if both day 7 and day 28 asexual
parasitemia were negative. According to the national treatment
policy, quinine (10 mg/kg, eight-hourly67 days) plus tetracycline
(8.3 mg/kg, eight-hourly67 days) was used at Pailin referral
hospital to treat P. falciparum recrudescent cases. DHA-PIP (Duo-
CotexinH, Zhejiang Holley Nanhu Pharmaceutical Co. LtdH) was
used for non-P. falciparum recrudescent cases.
Laboratory procedures
Microscopy examination. Microscopy blood slides were
stored in order to cross-check all RDT and PCR positive samples.
FSAT in Pailin, Cambodia
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Blood smears were stained with 3% Giemsa for 30 min at room
temperature. Asexual- and sexual-stage parasite counts were
performed by two experienced microscopists. In the case of a
discordant result, a third reading was done. Parasite densities were
determined from thick blood smears by counting the number of
asexual parasites per 200 WBCs (or per 500 WNCs, if the count
was less than 10 parasites/200 WBCs), assuming a WBC count of
8,000/ml. A smear was considered negative if no parasites were
seen after review of 100 high-power fields.
DNA extraction. DNA from blood spot collected in 96-well
PCR plate format containing patient screening samples and field
positive and negative controls were extracted with Instagene
Matrix resinH (Bio-RadH, France), according to the protocol
adapted from the suppliers recommendations and previously
described by Steenkeste et al. [11].
Nested PCR detection. Detection of Plasmodium was carried
out using primers targeting the Plasmodium cytochrome b gene as
described by Steenkeste et al. [11]. For positive samples, RFLP on
PCR products using AluI enzyme was performed for determining
Plasmodium species. Briefly, 5 ml of PCR products adjusted to
500 ng/ml were mixed with 0.2 ml of AluI and 2.5 ml of buffer A
according to the manufacturer’s instructions (New England
BiolabsH, France), incubated for 4 hours at 37uC and inactivated
at 65uC for 15 minutes. Bands were detected by standard 2%
agarose gel electrophoresis and ethidium bromide staining.
Plasmodium species identification was assessed according to the
number and the size of the bands: P. falciparum (2 bands, 640 and
159 bp), P. vivax (5 bands, 270, 249, 187, 169 and 111 bp), P. ovale
(2 bands, 584 and 224 bp) and P. malariae (3 bands, 381, 249 and
187 bp).
Detection of atovaquone resistance (codon 268). All P.
falciparum positive samples were screened for the Y268 mutations
in cytochrome b gene that have been related to atovaquone
resistance. PCR products from the outer PCR used to detect
malaria parasites (1385 pb) were used as template for two second
round PCRs. For both nested PCR (NsiI and SspI), amplification
took place in the following reaction mixture: 2.5 ml of 106buffer,
1.5 mM MgCl2, 0.2 mM each deoxynucleoside triphosphate,
0.5 mM each primer (forward primer NsiI, 59-ggtttacttggaacagtttt-
taacaatg-39, reverse primer NsiI, 59-ggtttacttggaacagtttttaacaatg-39
and forward primer SspI, 59-acagaataatctctagcacc-39, reverse
primer NsiI, 59-acctgaatggtactttctacaatat-39), 2 U of FirePol Taq
polymerase (Solis BiodyneH, Estonia), and 2 ml of PCR products.
Nested PCRs were performed under the following conditions:
heating at 94uC for 5 min, followed by 30 cycles of heating at
94uC for 30 s, 45uC (nested PCR NsiI) or 55uC (nested PCR SspI)
for 90 s, and 72uC for 2 min, and a final extension period at 72uC
for 10 min. Five ml of nested PCR products adjusted to 500 ng/ml
were respectively mixed with 0.2 ml of NsiI and 2.5 ml of buffer 3
(nested PCR NsiI) and with 0.2 ml of SspI and 2.5 ml of buffer 2
(nested PCR SspI) according to the manufacturer’s instructions
(New England BiolabsH, France), incubated for 4 hours at 37uC
and inactivated at 65uC (SspI) or 80uC (NsiI) for 20 minutes.
Bands were detected by standard 2% agarose gel electrophoresis
and ethidium bromide staining. Polymorphism at codon 268 was
assessed according to the number and the size of the bands:
Y268Y (tat) - NsiI RFLP (2 bands, 359 and 25 bp) and SspI (2
bands, 151 and 23 bp); Y268N (aat) - NsiI RFLP (2 bands, 359
and 25 bp) and SspI (1 band, 174 bp); Y268C (tgt) or Y268S (tct) -
NsiI RFLP (1 band, 384 bp) and SspI (2 bands, 151 and 23 bp).
Sequencing reactions. Plasmodium species identification and
mutations at codon 268 were secondly confirmed by sequencing.
Briefly, nested PCR products were purified by 96-well plate
filtration (MilliporeH, France) using a polyacrylamide gel (Bio-Gel
P-100H, Bio-RadH, France). Sequencing reactions were carried out
with the ABI Prism BigDye Terminator cycle sequencing ready
reaction kit run on a 3730 XL genetic analyzer (Applied
BiosystemsH, France). Electrophoregrams were visualized and
analyzed with Seqscape software v2. 0 (Applied BiosystemsH,
France). Amino acid sequences were compared with the following
sequences: GenBank accession no. NC002375 for P. falciparum,
AY598138 for P. vivax, NC007232 for P. knowlesi, AF069624 for P.
malariae and AB182496 for P. ovale, using BioEdit Sequence
Alignment Editor software [12].
Detection of G6PD deficiency. To determine which indi-
viduals should receive primaquine treatment, all individuals who
tested PCR positive were screened for G6PD deficiency from
backup blood spots according to the protocol developed by
Kuwahata et al [13]. As this method turned out to be unreliable in
identifying truly G6PD deficient individuals, by systematic over-
reporting, only those found to be surely not G6PD deficient
received primaquine, while an unknown number of false positives
in the test had to be excluded from receiving the additional
gametocidal treatment.
P. falciparum genotyping. Molecular genotyping tech-
niques were used to distinguish recrudescence from new infection
for all patients who failed therapy after day 7. Filter paper blood
samples collected on the day of enrolment and on the day of
failure were analyzed for polymorphisms in the genes for
merozoite surface protein 1 (msp-1), merozoite surface protein 2
(msp-2) and glutamate rich-protein (glurp) using nested-PCR as
described elsewhere [14]. In accordance with WHO recommen-
dations [15], treatment failure was labeled recrudescence if all
msp1, msp2 and glurp alleles present at the time of failure had been
present at the time of treatment initiation. In all other cases, the
failure was considered a new infection.
P. falciparum bar-coding. Bar-coding assays were per-
formed as previously described by Daniels et al. [16] with minor
modifications. Polymorphisms in eight SNPs were assessed
according to Daniels et al.’s assay numbering (assay number 3,
4, 7, 8, 9, 19, 20, 24) by nested PCR approach (Table S1). Second
PCR amplification was immediately followed by HRM ramping
from 65uC to 85uC with fluorescence data acquisition set at 0.2uC
increments. HRM analysis was performed by software supplied by
BioradH (CFX Manager 2. 1H, Bio-RadH, France), assigning
automatically the two possible nucleotides for each sample. In
each run, samples were analyzed in duplicate with 3D7 and Dd2
genomic DNA controls and no template control.
Statistical analysis
Data were entered and verified using Microsoft Excel softwareH
and analyzed using XLSTAT for Windows XPH (AddinsoftH,
France) and MedCalc software (version 9. 1. 0. 1, Belgium). The
Mann-Whitney U test or Kruskal-Wallis method were used for
non-parametric comparisons, and Student’s t test or one-way
analysis of variance for parametric comparisons. For categorical
variables, Chi-squared or Fisher’s exact tests were used to assess
significant differences in proportions. The efficacy outcomes were
28-day clinical and parasitological failure risks adjusted by
genotyping, in accordance with the 2009 WHO protocol [17].
Hypothesis testing was made using risk differences, exact 95%
confidence intervals, and P-values. A P-value (two-tailed) of less
than 0.05 was considered statistically significant.
Genetic diversity was assessed by Nei’s unbiased expected
heterozygosity (He) from haploid data and calculated as He= [n/
(n21)][12pi] (n = the number of isolates sampled; pi = the
frequency of the ith allele [18]. Population genetic differentiation
FSAT in Pailin, Cambodia
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was measured using Wright’s F statistics [19]. Population genetic
parameters were computed with FSTAT software, v2. 9. 4 [20].
Ethical clearance
The study protocol was reviewed and approved by the
Cambodian National Ethics Committee on Health Research
(NECHR) and by the Ethics Board of the WHO Western Pacific
Region office (WPRO). An informed written consent was provided
by the parents/guardians of all patients before testing.
Results
Population screening
The FSAT study was conducted from May to October 2010. A
total of 6,931 individuals were screened in the 20 selected villages.
The coverage achieved was 72.7% when counting all persons
present at the village at the moment of FSAT and their relatives
who were known but absent (6,931/9,537). The mean age of the
screened population was 23.7 years (SD, 617.1 years), ranging
from 1 week to 89 years. The mean gender ratio (male/female)
was 1.04, ranging from 1.32 (in Oh Tatus and Oh Trengleu
villages) to 0.88 (Bor Thmey). Risk classification according to the
movement of individuals showed that none of individuals declared
that they had come from or were be likely to go to Myanmar (‘‘risk
class A’’); 139 (1.6%) were identified to have a travel history to or
from Thailand and were classified as belonging to ‘‘risk class B’’;
8550 (94. 6%) declared that they had stayed or were likely to stay
within Pailin or local transmission areas within Cambodia (‘‘risk
class C’’); and 341 (3.8%) declared that they had come from or
were likely to proceed to non-malaria transmission areas within
Cambodia (‘‘risk class D’’). Three individuals (1 in Phnom
Dambang and 2 in Oh Preus) were said to work as maids in
Malaysia and were initially falsely classified as ‘‘risk class A’’.
However, given that they were most likely to work in an urban
area they were considered not be posing a risk to the spread of
malaria parasites from Pailin, they were removed from ‘‘risk class
A’’ and remain unclassified. No significant differences were
observed between villages with regard to risk classes. In the 20
villages, 621 individuals (8.9%) were febrile or sub-febrile with
axillary temperature ranging from 37.2uC to 40.0uC, with a mean
temperature of 37.4uC. Among them, only 7 (1.1%) were detected
positive by RDT: two with P. falciparum or mixed P. falciparum/non-
P. falciparum species (40 and 120 parasites/mL) and 5 with non-P.
falciparum species (2400, 4000, 4000, 12,000 and 16,000 parasites/
mL). Ten additional malaria cases were found by using PCR (17/
621, 2.7%): 3 with P. falciparum (32, 35 and 40 parasites/mL) and 7
with P. vivax (30, 32, 35, 40, 48, 53 and 187 parasites/mL). Detailed
information including microscopic results is presented in Table 1.
Analysis of 6931 dry blood samples by nested-PCR showed 133
(1.9%) positive samples (Table 2): 60 individuals were infected by
P. falciparum (0.9%, geometric mean of parasite density = 47
parasites/mL, range= 20–1,200 parasites/mL, interquartile
range = 32–52 parasites/mL), 72 by P. vivax (1.0%, geometric
mean of parasite density = 66 parasites/mL, range= 15–1,600
parasites/mL, interquartile range= 32–107 parasites/mL) and one
by P. malariae (0.01%, parasite density = 45 parasites/mL). The
mean time between sample collection and treatment was 8 days
(SD64 days).
Malaria epidemiology
Malaria positive cases. Six out of the 20 villages screened
were free of malaria parasites: Rothkros Chhes, Phnom Rang, Oh
Treng, Andong Py, Phitas Sbov and Phnom Spung. Temporal
evolution of the proportion of malaria parasites carriers showed
significant difference according to the month of the collection for
the most prevalent species, P. falciparum (P=0.0001) and P. vivax
(P=0.0003) (Figure 2). All malaria positive cases had declared
having stayed or were likely to stay within Pailin or local
transmission areas within Cambodia.
P. falciparum cases. Sixty P. falciparum infections were found
in 9 villages (11 out of the 20 villages were P. falciparum cases free).
The prevalence of P. falciparum infections was not significantly
different between adults (0.94%) and children under the age of 15
(0.74%) (P=0.36) and between males (1.02%) and females (0.72%)
(P=0.18).
According to the classification of villages, the mean prevalence
of asymptomatic parasite carriers was not significantly different
between ‘‘high risk’’ villages and ‘‘low risk’’ villages based on HC
2009 data (0.38% vs. 0.59%, P=0.41). In contrast, there was a
statistically significant correlation between the mean prevalence of
parasite carriers of ‘‘high risk’’ and ‘‘low risk’’ villages identified by
VMW in 2009 (1.41% vs. 0.59%, P=0.04). While the FSAT
investigation was being conducted from May to end of October
2010 detecting almost exclusively asymptomatic parasite carriers,
the disease surveillance system in Pailin continued to detect and
parasitologically confirm the incidence of symptomatic carriers. At
the end of the year a re-classification of high and low risk villages
became possible based on the newly available incidence data of
2010 using the same selection criteria as for 2009 incidence
reports. Even though the reported incidence of P. falciparum had
fallen by 73.4% (from 941 to 250) in 2010, 11 out of the initial 15
high risk villages remained among the ten with highest case reports
in the two HC and VMW disease surveillance systems (Malaria
Consortium, unpublished data). The analysis of the FSAT results
showed that the correlation between the prevalence of asymp-
tomatic carriers and disease incidence reports (both surveillance
systems) of the same year was highly significant. ‘‘High risk HC
2010’’ villages had on average six times more asymptomatic
carriers than ‘‘low risk HC 2010’’ villages (1.57% vs. 0.24%,
P,1024). A very similar result was observed when comparing
‘‘high risk VMW 2010’’ villages with ‘‘low risk VMW 2010’’
villages (1.48% vs.0.24%, P,1024) (Table S2). Based on 2010
cases report, the prevalence was significantly higher in ‘‘high risk
HC/VMW 2010’’ villages compared to ‘‘low risk HC/VMW
2010’’ villages (1.10% vs. 0.27%, P=0.005). P. falciparum
prevalence was not significantly different between adults and
children (0.94% vs. 0.74%, P=0.36) and between males and
females (1.02% vs. 0.72%, P=0. 18). The spatial distribution of P.
falciparum prevalence according to malaria incidence reported
through HC and VMW in 2009 (Panel 1) and in 2010 (Panel 2) is
shown in Figure 3.
P. falciparum genetic diversity and gene flow. Eight-
locus genotyping of P. falciparum isolates displayed 17 different
haplotypes. Twelve haplotypes (70%) were found solely in several
villages: Pekiri (Nu3, 4, 9 & 11), Bor Thmey (Nu2, 12, 13, 14 & 17),
Andong Thmor (Nu8 & 16) and Oh Chrakandal (Nu15) while the
others were shared between villages: Nu1 (Oh Sour Sdey & Pekiri),
Nu5 (Bor Tang Sou & Pekiri), Nu6 (Bor Thmey, Krachab Krom,
Oh Chrakandal, Oh Roel & Pekiri), Nu7 (Bor Thmey, Krachab
Krom, Oh Soursdey & Pekiri), Nu10 (Bor Tangsou, Bor Thmey,
Oh Roel, Oh Soursdey, Oh Tantramdey & Pekiri). Genetic
diversity, assessed by Nei’s unbiased expected heterozygosity (He)
ranged from 0.06 (Oh Roel) to 0.33 (Bor Thmey) and was
significantly higher in Bor Thmey compared to Pekiri (0.3360. 9
vs. 0.1960.12, P=0.01, Table 3). The degree of genetic
differentiation within P. falciparum populations, estimated by Fst
values, indicated divergence between villages, except for Bor
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Table 1. Characteristics of individuals screened during the FSAT project and prevalence of malaria-infected people detected by
RDT among febrile individuals, Pailin, Cambodia, 2010.
Village ID Village name
Incidence classification
from health system
(2009) Population size Sample collection Age (years) Gender
Number % Mean M/F ratio
1 Krachab Krom High Risk HC 767 701 91.4% 23.9 0.92
2 Phnom Dambang High Risk HC/VMW 525 375 71.4% 22.6 1.16
3 Oh Tatus Low Risk 174 140 80.4% 25.1 1.31
4 Oh Preus High Risk VMW 997 713 71.5% 23.6 1.03
5 Krachab Leu High Risk HC 529 380 71.8% 23.5 1.05
6 Rothkros Chhes Low Risk 210 139 66.2% 25.2 1.10
7 Phnom Rang High Risk HC 428 334 78.0% 24.4 1.10
8 Oh Sour Sdey High Risk VMW 347 229 65.9% 23.2 0.97
9 Prey Mang Kul High Risk HC/VMW 459 359 78.2% 24.9 0.99
10 Andong Thmor High Risk VMW 412 281 68.2% 22.8 1.08
11 Oh Tontram Dey Low Risk 196 127 64.8% 24.2 0.94
12 Oh Roel High Risk HC 1022 731 71.5% 24.3 1.04
13 Bor Thmey High Risk HC 392 282 71.9% 23.3 0.87
14 Oh Treng High Risk HC/VMW 101 69 68.3% 22.2 1.34
15 Oh Char Kandal Low Risk 422 306 72.5% 24.5 0.94
16 Pekiri High Risk VMW 771 530 68.7% 23.0 1.07
17 Bor Tang Sou High Risk HC 662 445 67.2% 23.2 1.03
18 Andong Py High Risk VMW 387 236 60.9% 23.9 1.04
19 Phitas Sbov Low Risk 413 306 74.1% 23.2 1.17
20 Phnom Spung High Risk HC 323 248 76.8% 22.8 1.12
9537 6931 72.6% 23.7 1.04
Risk classification RDT (if T6.37,26C) Microscopy results (parasite/mL)
Aa B C D performed (%) positive (% ) P. falciparum P. vivax
falciparum Non-falciparum
0,0% 0.0% 97.1% 2.9% 104 (14.8%) 0 0 - -
0.0% 5.9% 88.0% 6.1% 41 (10.9%) 0 1 (2.4%) - 4000
0,0% 0.6% 97.1% 2.3% 17 (12.1%) 0 0 - -
0.0% 1.4% 95.3% 3.3% 82 (11.4%) 0 2 (2.4%) - 16000 & 4000
0,0% 0.0% 96.2% 3.8% 32 (8.4%) 0 0 - -
0,0% 0.0% 97.6% 2.4% 6 (4.3%) 0 0 - -
0,0% 0.5% 96.9% 2.6% 36 (10.8%) 0 0 - -
0.0% 2.6% 90.7% 6.7% 12 (5.2%) 0 1 (8.3%) 12000
0,0% 0.2% 96.1% 3.7% 31 (8.6%) 0 1 (3.2%) 2400
0.0% 3.1% 93.5% 3.4% 42 (14.9%) 0 0 - -
0,0% 3.0% 92.4% 4.6% 5 (3.9%) 0 0 - -
0,0% 0.6% 97.5% 1.9% 36 (4.9%) 1 (2.8%) 0 40
0,0% 1.5% 96.2% 2.3% 7 (2.5%) 1 (14.3%) 0 120
0.0% 0.0% 93.0% 7.0% 4 (5.8%) 0 0 - -
0,0% 0.7% 97.4% 1.9% 1 (0.3%) 0 0 - -
0.0% 1.3% 93.9% 4.8% 56 (10.6%) 0 0 - -
0,0% 0.6% 95.3% 4.1% 14 (3.1%) 0 0 - -
0.0% 0.5% 95.4% 4.1% 18 (7.6%) 0 0 - -
0,0% 5.1% 87.1% 7.8% 50 (16.3%) 0 0 - -
0,0% 3.1% 93.8% 3.1% 27 (10.9%) 0 0 - -
0.0% 1.6% 94.6% 3.8% 621 (8.9%) 2 5
aThree persons (0. 03%, 1 in Phnom Dambang and 2 in Oh Preus) were said to work as maids in Malaysia and were initially falsely classified as ‘‘A’’ but have to remain
unclassified. However, given that they were most likely to work in an urban area they were considered not be posing a risk to the spread of malaria parasites from Pailin.
doi:10.1371/journal.pone.0045797.t001
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Figure 2. Temporal evolution of the proportion of malaria parasites carriers, Pailin, Cambodia, 2010.
doi:10.1371/journal.pone.0045797.g002
Figure 3. Spatial distribution of P. falciparum prevalence according to malaria incidence reported through HC and VMW in 2009
(Panel 1) and in 2010 (Panel 2), Pailin, Cambodia, FSAT 2010.
doi:10.1371/journal.pone.0045797.g003
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Thmey and Pekiri (Fst = 0.00139, P.0. 05), highlighting a parasite
flow between these two villages.
P. vivax cases. Seventy two P. vivax infections were found in
12 villages (8 out of the 20 villages screened had no P. vivax cases).
P. vivax infections were significantly more prevalent in adults
(1.24% vs. 0.74%, P=0.046), but no significant difference was
found between males and females (1.13% vs. 0.80%, P=0.15).
Spatial distribution of P. vivax prevalence is shown in Figure 4
(Panel B).
G6PD deficiency screening. Screening of G6PD deficiency
by using blood spots among the malaria infected cases gave results
which were considered skewed towards artificially low G6PD
enzyme activity levels due to methodical problems, as explained in
the discussion section. The global prevalence of G6PD deficient
people among parasites carriers was estimated to 63% (18% with
10%–30% of enzyme activity and 45% ,10% of enzyme activity).
Polymorphism at codon 268 in cytb gene. Among the 60
P. falciparum cases, all parasites were wild-type (Y268).
Treatment outcomes of P. falciparum cases. Five differ-
ent antimalarial regimens were given to 57 of 60 P. falciparum cases:
AP (n= 25), AP+PQ (n= 25), CQ (n= 1, wrongly given), QN
(n= 1, pregnant woman) and DHA-PIP (n= 5, at the beginning of
the study when AP was not available). Three individuals were lost
(had left their villages to Preah Vihear, n= 1 or Kampot provinces,
n = 2). The 28-day follow-up data were available for 51 patients.
One patient treated with DHA-PIP failed and was classified as
treatment failure following genotyping. One patient treated with
AP developed vivax malaria at day 28.
Treatment outcomes of P. vivax cases. For P. vivax cases,
59 patients received CQ alone and only 11 patients received CQ
with PQ due to the many false positive G6PD tests. Two
individuals were lost (had left their villages to Prey Veng, n= 1 or
Battambang provinces, n = 1). The 28-day follow-up data were
available for 64 patients. Both CQ and CQ+PQ were 100%
effective in clearing P. vivax infections.
Discussion
The emergence of artemisinin resistance in western Cambodia
demanded urgent action to contain its spread and eliminate
malaria in identified foci [21]. To contain this threat, a number of
strategic priorities were identified and implemented rapidly, such
as the mass deployment of LLINs, the banning artemisinin
monotherapies and the strengthening of public sector provision of
free parasitological diagnosis and treatment through VMWs and
HCs. However, there was a paucity of epidemiological informa-
tion on which to base the planning of additional interventions and
a lack of operational experience in Cambodia and elsewhere in
implementing potential new tools for elimination. At this stage
PCR based diagnosis was limited to epidemiologically explore the
reservoir of parasites in asymptomatic carriers.
The most encouraging epidemiological insight gained from
FSAT was to that seems extremely low. Out of the 6,931 persons
screened and among the 2,606 family relatives of the screened who
were absent at the time of screening, none had any travel history to
or from Myanmar. Although there is long history of presence of
Burmese gem miners in Pailin [22–24], two widely corroborated
phenomena may explain the complete absence, since several years
now, of any Burmese in Pailin: (i) the former abundance of rubies
and others gems has now been depleted and (ii) alternative
attractive economic opportunities do not exist in Pailin for
foreigners, due to lower salary levels when compared to similar
activities on the Thailand side of the border.
There had also been concerns that artemisinin resistance might
spread indirectly from Palin to Myanmar via temporary or
permanent residents of Pailin when migrating to areas of local
transmission on the Thailand side of the border, to work in
orchards, rubber or plantations or in the fishing industry at the
coast in which many Burmese are working [25–27]. Here again,
the results were encouraging as only as 139 (1.47%) of the 9537
persons registered through the survey qualified to be included into
the ‘‘risk group B’’ for AR spread as ‘‘likely to go to malaria
transmission areas in Thailand’’. All malaria positive cases
reported to have stayed in Pailin or local transmission areas in
Cambodia in the preceding year. Only 8/6931 persons tested
(0.12%) had a travel history to Thailand, all of them being PCR
negative. All others did not have any travel history that could pose
a risk to containment of P. falciparum spread outside of Pailin.
However, temporary migrations of seasonal workers from
Cambodia to Thailand seem to be likely responsible for the
parasite gene flow that we have observed between villages along
the Cambodian-Thailand border (i.e. Bor Thmey) and villages
inside Pailin province (i.e. Pekiri).
Until the launch of the FSAT project, there were concerns that
the existing health information system (HIS), and in particularly
the HC incidence data would not accurately identify foci of
infection because it is known that patients in Cambodia seek
treatment in the private sector, especially if they are far away from
public health facilities [28–30]. In addition, the villages with
higher burdens of symptomatic malaria – (indicative of relatively
Table 3. Genetic diversity at village level expressed as mean expected Heterozygosity (He) using eights SNPs in P. falciparum
collected in Pailin, Cambodia, 2010.
Village No. of P. falciparum No. of haplotypes Mean He of 8 loci (±SD)
Andong Thmor 2 2 0. 1660. 31
Bor Tang Sou 2 2 0. 1660. 31
Bor Thmey 8 8 0. 3360. 19
Krachab Krom 2 2 0. 0860. 23
Oh Char Kandal 4 2 0. 1460. 26
Oh Roel 3 2 0. 0660. 18
Oh Sour Sdey 4 3 0. 2360. 25
Oh Tontram Dey 2 1 -
Pekiri 33 9 0. 1960. 12
doi:10.1371/journal.pone.0045797.t003
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non-immune populations) might be different from those villages in
which the inhabitants were more immune and had higher levels of
asymptomatic carriage. These villages might therefore be harbor-
ing a large parasite reservoir. However our results showed a good
correlation between the high burden villages as identified by the
HIS data on incidence of symptomatic cases of 2010. The passive
case detection incidence data recorded by the VMWs was already
significantly identifying the villages with higher burdens of
asymptomatic carriage in 2009 as well as in 2010.
The VMWs are clearly a critical component of the containment
strategy. As shown here, not only are they instrumental in
reducing population parasite burden by providing easy access to
good quality diagnosis and treatment, but they are a critical
component of the surveillance system [31]. Currently, they only
operate in the 43 out of 109 villages in Pailin, which are located
more than 5 km away from the nearest health center. Given their
important role they can play in containment, expansion of the
scheme to include all villages in Pailin should be considered [32].
FSAT proved achievable logistically, the complex protocol of
screening, treatment and follow up of over 6’000 individuals was
sustained over six months. In addition, FSAT has generated
scientific results on patterns of infection and quantified the risks of
potential drug resistant parasites spread outside of Pailin. This
operational success under difficult field conditions suggests that
FSAT might be a feasible method for cross-sectional screening
with PCR and directly observed treatment in other settings. A high
level of case identification and treatment was achieved despite
there being a mean lapse of 8 days between the day of screening
and the case being located by the follow-up team. Out of the P.
falciparum cases that were detected by PCR, 95% could be traced
for follow-up. Of those who could remain in the study all adhered
to the directly observed three days of treatment. Of these cases,
96% were followed up until day 28. P. falciparum parasites
Figure 4. Spatial distribution of P. vivax prevalence, Pailin, Cambodia, 2010.
doi:10.1371/journal.pone.0045797.g004
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circulating in Pailin province were found to be sensitive to
atovaquone (none of them being mutant-type at codon 268) and
asexual parasites totally sensitive to AP. Only one case of
treatment failure was observed from an individual treated with
DHA-PIP. This observation was not surprising due to high level of
recrudescence (,25%) recently found in this area (Leang et al.,
submitted 2012).
A number of important lessons were learnt which may help to
inform the future programme implementation. The main chal-
lenge was the lack of accurate information on the size and location
of the population because of the amount of population movement
in the area. As noted elsewhere, much of this movement is dictated
by the seasonal agricultural calendar [26]. The estimates in
population size therefore varied considerably making it difficult to
accurately calculate coverage rates. Population estimates based on
a previous census data were on average 43.7% higher (range:
18.5–66.7%) than the estimates made by the FSAT team with the
help of village leaders and based on the population estimates
during FSAT, the mean coverage rate was 72.1% (range: 61.0%–
91.4%). Transporting blood samples from the field for analysis in
the laboratory in Phnom Penh also proved problematic, not only
because of the resulting delay between screening and treatment of
positive cases, but also the accuracy of some of the results,
particularly the G6PD results. The high levels of G6PD deficiency
reported here compared to the likely true prevalence of around
10%, [33] were thought to be due partly to the high threshold
(,30% of the normal enzyme activity) chosen to declare a person
as deficient. In addition, a deterioration of the samples during
transportation to Phnom Penh, a day’s drive away from the
villages was very likely. For this reason a mobile laboratory has
since been purchased to improve the speed and the reliability of
FSAT. In Cambodia, PCR can now be carried out in the field by
placing the mobile laboratory within the target villages reducing
the interval time between sample collection and treatment of
positive cases to 24 hours. In addition, the detection of mutation at
codon 268 in cytochrome b gene and G6PD deficiency screening
can now be similarly carried out within the same time and
expected increases in reliability. Moreover, the blood sample
analysis within the village is likely to render this practice more
acceptable and interesting for the population, increasing the
coverage rates.
Given the impossibility of carrying out MSAT at the scale
originally envisaged, mainly for reasons of lack of human resources
in Cambodia, a strong case has been made in favour of Mass Drug
Administration (MDA) throughout Pailin as a radical measure to
rapidly eliminate P. falciparum from the province. The arguments
in favour of MDA include the slowness of FSAT (screening speed
of one village per week) and the possibility that there would be
asymptomatic carriers under the low parasitaemia threshold of
PCR of 0.1 parasites/ml who might escape detection. However,
the main difficulty encountered during FSAT (i. e. that of high
population movements into, within and out of Pailin) would also
be encountered by MDA. But, in contrast to FSAT and MSAT,
MDA would also make any epidemiological analysis impossible
and effectively render the programme blind as to the location of
last remaining foci of transmission. Finally, the rapid geographical
widening of drug pressure caused by MDA, followed by a longer
period of mass exposure of sub-lethal plasma concentrations of the
drug used, present simultaneously in large sections of the
population, could trigger the very selection and emergence of
multi-drug resistant parasite populations that many so rightly fear.
This would be particularly true for AP if it was to be used for
MDA, as only one single mutation in the parasite’s genome could
render this drug ineffective as have successively become all its
predecessors throughout Pailin [34].
In conclusion, FSAT may be a useful additional tool in the
containment of AR parasites, among the other strategies
implemented, albeit its shortcomings in terms of slowness and
coverage in three important ways: (i) by providing information on
travel and migrations patterns, (ii) by identifying clusters of
asymptomatic carriers and (iii) by reducing the overall parasite
biomass through the identification and treatment of infections that
would otherwise have been undetected. However, recent a report
demonstrating the emergence of AR malaria along the Myanmar-
Thailand border emphasize the need to expand containment
efforts and to further improve surveillance strategies [35]. These
might include PCR-based FSAT as new epidemiological tool to
help direct containment efforts or malaria elimination in other
contexts [36,37]
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